Hosted on MSN
Why Autoimmune Diseases Rise Sharply After 50
Fatigue, joint pain, rashes, brain fog or tingling in the hands and feet can seem like normal signs of aging—but they may also point to an autoimmune disease. These potentially disabling and often ...
A study found summer food insufficiency rose 4 percentage points among low-income households with children, while first-year Summer EBT participation was low and showed no measurable effect. A small, ...
A population-based study has shown a slightly elevated risk for patients’ developing skin disorders, including alopecia areata (AA), alopecia totalis (AT), vitiligo, and bullous pemphigoid (BP), more ...
Medically reviewed byJimmy Almond, M.D. Vitiligo is a common autoimmune disease in which the immune system mistakenly attacks and destroys melanocytes, the cells that give skin its color, causing ...
Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic ...
The initiation, progression, and remission of autoimmune skin diseases are multifactorial—akin to the rolling of several “etiology dice.” (a) In healthy individuals, autoimmune responses are kept ...
Patients with autoimmune skin diseases (ASDs) showed significantly lower risks for death after cancer treatment than those without ASDs, especially those with alopecia areata or Sjögren syndrome. A ...
New research suggests psoriasis, a common skin disease with no cure, could be treated with a B-vitamin nutritional supplement.
HORSHAM, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (Nasdaq: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative dermatologic ...
Add Yahoo as a preferred source to see more of our stories on Google. While many conditions are invisible, that's not the case when it involves your skin. Rashes, bumps, lesions or discoloration are ...
Hosted on MSN
Immunovant ends autoimmune skin disorder program
Roivant Sciences Ltd. ROIV announced that Immunovant Inc. IMVT plans to halt the development of IMVT-1402 as a treatment for cutaneous lupus erythematosus (CLE). The decision follows recent ...
HORSHAM, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in excimer laser therapy for inflammatory and autoimmune dermatologic diseases, today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results